No Data
No Data
Guangji Pharmaceutical: Semi-Annual Report 2024
Guangji Pharmaceutical: 2024 Semi-Annual Report Summary
Hubei Guangji Pharmaceutical (000952.SZ) released its performance for the first half of the year, with a net loss of 107 million yuan.
Hubei Guangji Pharmaceutical (000952.SZ) has released its 2024 interim report, during the reporting period, the company achieved revenue...
Hubei Guangji Pharmaceutical: 2024 Interim Performance Forecast
Guangji Pharmaceutical (000952.SZ): The company uses microbial fermentation to produce vitamin B2
Gelonghui, May 9 | Guangji Pharmaceutical (000952.SZ) said on the investor interactive platform that the company uses microbial fermentation to produce vitamin B2.
Hubei Guangji Pharmaceutical Co., Ltd. (SZSE:000952) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
No Data
No Data